Advent Pharma Ltd. (DSE:ADVENT)

Advent Pharma Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	0.9	1.77	3.97	1.07	4.31	2.69
Short-Term Investments	-	-	-	-	-	40
Cash & Short-Term Investments	0.9	1.77	3.97	1.07	4.31	42.69
Cash Growth	-75.14%	-55.41%	269.51%	-75.11%	-89.89%	-7.88%
Receivables	257.1	188.52	142.81	126.49	116.17	114.02
Inventory	79.91	66.17	67.24	79.75	81.33	75.41
Prepaid Expenses	-	-	0.05	0.05	0.05	0.04
Other Current Assets	28.19	28.15	28.01	29.83	32.72	29.81
Total Current Assets	366.1	284.61	242.08	237.2	234.59	261.98
Property, Plant & Equipment	1,614	1,648	1,615	1,551	1,409	1,258
Total Assets	1,981	1,932	1,857	1,788	1,644	1,520

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	9.95	10.08	9.64	20.6	10.42	8.92
Accrued Expenses	56.89	47.49	43.87	61.51	48.74	38.96
Short-Term Debt	61.24	58.67	60	54.99	43.27	36.83
Current Portion of Long-Term Debt	7.91	7.91	7.91	7.91	7.91	7.91
Current Portion of Leases	-	0.7	0.67	0.76	0.64	0.61
Current Income Taxes Payable	61.55	60.12	54.69	53.3	55.6	52.41
Other Current Liabilities	5.16	3.9	12.1	7.24	2.99	6.67
Total Current Liabilities	202.71	188.86	188.88	206.32	169.57	152.31
Long-Term Debt	6.71	7.43	7.43	7.43	11.02	14.56
Long-Term Leases	1.78	1.08	-	0.49	1.08	-
Long-Term Deferred Tax Liabilities	211.83	204.4	190.41	175.2	148.56	118.99
Other Long-Term Liabilities	-0	-	-	-	-	-
Total Liabilities	423.03	401.77	386.72	389.44	330.23	285.86

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	931.33	931.33	931.33	931.33	931.33	913.07
Retained Earnings	626.2	599.04	538.68	467.73	382.12	321.11
Shareholders' Equity	1,558	1,530	1,470	1,399	1,313	1,234
Total Liabilities & Equity	1,981	1,932	1,857	1,788	1,644	1,520

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	77.65	75.79	76.01	71.59	63.92	59.91
Net Cash (Debt)	-76.75	-74.03	-72.04	-70.52	-59.61	-17.22
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.83	-0.79	-0.77	-0.76	-0.64	-0.18
Filing Date Shares Outstanding	88.04	93.13	93.13	93.13	93.13	93.13
Total Common Shares Outstanding	88.04	93.13	93.13	93.13	93.13	93.13
Working Capital	163.39	95.75	53.2	30.88	65.02	109.67
Book Value Per Share	17.69	16.43	15.78	15.02	14.10	13.25
Tangible Book Value	1,558	1,530	1,470	1,399	1,313	1,234
Tangible Book Value Per Share	17.69	16.43	15.78	15.02	14.10	13.25
Land	-	3.78	3.78	3.78	3.78	3.78
Buildings	-	1,245	1,245	1,245	1,123	925.16
Machinery	-	570.15	530.34	527.92	458.43	442.57
Construction In Progress	-	178.95	124.58	15.86	7.39	29.72

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error